Access to effective smoking cessation medications in patients with medicare, medicaid and private insurance
Objectives: Compare financial barriers to the most effective smoking cessation medications - varenicline and combination nicotine replacement therapy (CNRT) across major insurance categories and determine whether these financial barriers impact smoking cessation outcomes. Study design: Longitudinal...
Saved in:
Main Authors: | Luisa Masclans (Author), James M. Davis (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Diagnosed Dementia on Medicare and Medicaid Program Costs
by: Padmaja Ayyagari, et al.
Published: (2007) -
Is Health Care Spending Higher under Medicaid or Private Insurance?
by: Jack Hadley, et al.
Published: (2003) -
The Center for Medicare and Medicaid Innovation: The Case for Reform
by: Doug Badger MDiv
Published: (2022) -
Potential Effect of Medical Insurance on Medicare: Evidence from China
by: Yongqiu WU, et al.
Published: (2016) -
Collaboration Between Oregon's Chronic Disease Programs and Medicaid to Decrease Smoking Among Medicaid-Insured Oregonians With Asthma
by: R. David Rebanal, MPH, et al.
Published: (2005)